Shepherd Kaplan Krochuk’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,000
| Closed | -$28.7K | – | 58 |
|
|
2024
Q1 | $28.7K | Hold |
12,000
| – | – | 0.02% | 54 |
|
|
2023
Q4 | $19.9K | Hold |
12,000
| – | – | 0.02% | 54 |
|
|
2023
Q3 | $23K | Hold |
12,000
| – | – | 0.02% | 52 |
|
|
2023
Q2 | $17.3K | Hold |
12,000
| – | – | 0.01% | 52 |
|
|
2023
Q1 | $25.2K | Hold |
12,000
| – | – | 0.02% | 55 |
|
|
2022
Q4 | $13.6K | Hold |
12,000
| – | – | 0.01% | 71 |
|
|
2022
Q3 | $20K | Hold |
12,000
| – | – | 0.01% | 138 |
|
|
2022
Q2 | $16K | Hold |
12,000
| – | – | 0.01% | 180 |
|
|
2022
Q1 | $19K | Hold |
12,000
| – | – | 0.01% | 182 |
|
|
2021
Q4 | $25K | Hold |
12,000
| – | – | 0.01% | 184 |
|
|
2021
Q3 | $47K | Hold |
12,000
| – | – | 0.02% | 182 |
|
|
2021
Q2 | $38K | Hold |
12,000
| – | – | 0.01% | 182 |
|
|
2021
Q1 | $26K | Sell |
12,000
-575
| -5% | -$1.25K | 0.01% | 175 |
|
|
2020
Q4 | $28K | Buy |
12,575
+575
| +5% | +$1.28K | 0.01% | 174 |
|
|
2020
Q3 | $32K | Hold |
12,000
| – | – | 0.01% | 168 |
|
|
2020
Q2 | $37K | Buy |
+12,000
| New | +$37K | 0.02% | 170 |
|